News

John Hancock Fund Announces September 2025 Distribution Details

John Hancock Fund Announces September 2025 Distribution Details

John Hancock Tax-Advantaged Dividend Income Fund Distribution Notice

The John Hancock Tax-Advantaged Dividend Income Fund (NYSE: HTD) has provided crucial updates regarding its monthly distribution of $0.1580 per share. This distribution is available to all shareholders who are on record as of September 12, 2025, as part of the Fund's managed distribution plan. This communication follows the guidelines required by an order granted by the Securities and Exchange Commission.

Overview of Distribution Sources

This announcement elaborates on the sources of the distribution declared recently. The fund aims to inform its shareholders about how the distribution is sourced and the cumulative figures for this fiscal year so far. Here are some key insights:

Monthly Distribution Amount

The distribution amount for September 2025 is confirmed to be $0.1580 per common share. Understanding this figure is essential for shareholders as it reflects the Foundation's effort to provide steady returns to its investors.

Sources of Distribution Breakdown

The following breakdown highlights the estimated sources contributing to the upcoming distribution:

  • Net Investment Income: $0.1274 (81% of current distribution)
  • Net Realized Short-Term Capital Gains: $0.0000 (0% of current distribution)
  • Net Realized Long-Term Capital Gains: $0.0000 (0% of current distribution)
  • Return of Capital: $0.0306 (19% of current distribution)

This breakdown serves as an essential guide for understanding where the distribution funds originate, and helps steer investment perspectives regarding potential returns.

Investor Guidance and Considerations

It is important for investors not to draw definitive conclusions regarding the Fund's performance merely based on the distribution amount. The Fund anticipates that it may have distributed more than its income and net capital gains, meaning that a portion of each distribution could be returned capital. Such returns should not be interpreted as income or yield.

Tax Reporting Considerations

The estimates and sources of the distributions mentioned are preliminary and subject to adjustments based on the Fund’s performance during the remaining fiscal year. For tax reporting purposes, shareholders will receive Form 1099-DIV, which will detail how distributions should be filed when reporting federal income tax.

Managed Distribution Plan Overview

Under the current managed distribution plan, the Fund has committed to making consistent distributions to its shareholders, currently set at $0.1580 per share. This strategy aims to ensure shareholders can rely on their Fund returns being paid out monthly, without interruption.

Contact Information for Shareholders

If you have any questions or require further details regarding your investment, you are encouraged to reach out to your financial advisor. Alternatively, assistance can be sought by calling the Manulife John Hancock Closed-End Fund Information Line at 1-800-843-0090, available Monday to Friday from 8:00 a.m. to 7:00 p.m. Eastern Time.

Frequently Asked Questions

What is the distribution amount for September 2025?

The distribution amount is confirmed at $0.1580 per share for September 2025.

What sources contribute to the distribution?

The main sources include net investment income, capital gains, and return of capital.

How is the return of capital defined?

A return of capital may occur when part of the invested money is paid back to shareholders and does not portray the investment's performance.

When will shareholders receive Form 1099-DIV?

Form 1099-DIV will be sent at year-end to provide necessary tax reporting details.

How can I get more information about my investment?

Shareholders can contact their financial advisor or call the Manulife information line at 1-800-843-0090 for assistance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 13

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 8

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 2

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 0

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 7

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 15

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 0

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 5

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing SLB's Market Dynamics and Investor Sentiment Trends

Updated Category News Views 122

Understanding SLB's Market Position SLB's short percent of float has decreased by 9.27% since its last report, revealing important trends in investor sentiment. Recently, the company disclosed that it has 61.95 million shares sold short, amounting to 4.6% of the total shares available for trading. Analyzing this information provides valuable insight into how traders...

Continue Reading
Insight into Debtor Composition for Bond Issuance Announcements

Updated Category News Views 97

Understanding Debtor Composition in Bonds In the dynamic world of financial markets, understanding the debtor composition is crucial for investors and stakeholders alike. Recently, Jyske Realkredit released data on the debtor composition related to its bonds, as mandated by the Capital Markets Act. What is Debtor Composition? Debtor composition refers to the breakdown of...

Continue Reading
Valid Eval Awarded NASA Contract to Enhance Evaluation Systems

Updated Category News Views 135

Valid Eval Receives SBIR Contract from NASA Valid Eval, recognized for its innovative secure SaaS platform that facilitates complex group evaluations, has achieved a significant milestone by securing a Phase III Small Business Innovation Research (SBIR) contract from NASA. This contract marks a noteworthy step forward in managing NASA's SBIR/STTR program applicant...

Continue Reading
Klaviyo's Bright Future: Stifel Sees Growth and Potential

Updated Category News Views 42

Stifel Gives Klaviyo a Buy Rating Klaviyo (NYSE: KVYO) has made its mark in the marketing automation sector, and recently, Stifel has recognized this by initiating coverage with a Buy rating. This comes with a targeted price set at $45, highlighting the confidence in Klaviyo’s capacity to harness the burgeoning digital marketing environment. Stifel analysts point to the...

Continue Reading
Jay-Z's Inspiring Journey to Wealth and Emotional Growth

Updated Category News Views 435

Jay-Z's Evolution: From Survival to Emotional Intelligence Shawn Carter, widely known as Jay-Z, has emerged as a beacon of inspiration, particularly after being recognized by prominent investor Warren Buffett as “the guy to learn from.” This iconic rapper's journey, deeply rooted in his Brooklyn upbringing, exemplifies a profound transformation and growth that extends...

Continue Reading